We are live on ! Find out more
QNTM

Quantum Biopharma Class B Subordinate Voting Shares
QNTM

25 hedge funds and large institutions have $1.23M invested in Quantum Biopharma Class B Subordinate Voting Shares in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 5 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

3.3% more ownership

Funds ownership: 3.36% → 6.66% (+3.3%)

Holders
25
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$266K
2
+$185K
3
+$92.9K
4
Mariner
Mariner
Kansas
+$45.4K
5
UBS Group
UBS Group
Switzerland
+$24.9K

Top Sellers

1
-$89.8K
2
-$4.21K
3
-$1.77K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$162
5
SEP
Signature Equity Partners
Ohio
-$146
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
–
Morgan Stanley
27
Morgan Stanley
New York
–
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
–
SEP
29
Signature Equity Partners
Ohio
–
Bank of America
30
Bank of America
North Carolina
–
1
2